Conversely, in the F-TBRS (TGF-β response signature) and angiogenesis pathways, the gene expression levels in the HH groups were lower than those in the HL groups (p = 0.0293 and 0.0235) (Fig. 5b; Supplementary Fig. 10). The gene discussed is TGFB1; the disease is Hodgkins lymphoma.